We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.59B
AUM Growth
-$78.5M
Cap. Flow
-$53.5M
Cap. Flow %
-1.49%
Top 10 Hldgs %
13.47%
Holding
1,643
New
159
Increased
579
Reduced
611
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$52.5M
2
AFL icon
Aflac
AFL
+$24.1M
3
WLY icon
John Wiley & Sons Class A
WLY
+$18.9M
4
KMX icon
CarMax
KMX
+$17.5M
5
BIIB icon
Biogen
BIIB
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.39%
2 Energy 10.37%
3 Financials 10.35%
4 Technology 9.89%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOBE
551
DELISTED
Bob Evans Farms, Inc.
BOBE
$1.28M 0.04%
+25,184
New +$1.17M
FR icon
552
First Industrial Realty Trust
FR
$8.73B
$1.27M 0.04%
67,750
+1,500
+2% +$30K
KEX icon
553
Kirby Corp
KEX
$7.01B
$1.27M 0.04%
16,521
+721
+5% +$57.1K
CAG icon
554
Conagra Brands
CAG
$6.94B
$1.26M 0.04%
37,065
-122,432
-77% -$3.68M
CCK icon
555
Crown Holdings
CCK
$12.8B
$1.26M 0.04%
23,785
-210
-0.9% -$11.6K
XLI icon
556
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
$1.25M 0.03%
23,197
-301
-1% -$16.9K
DBD
557
DELISTED
Diebold Nixdorf Incorporated
DBD
$1.25M 0.03%
35,730
+900
+3% +$31.7K
VIAB
558
DELISTED
Viacom Inc. Class B
VIAB
$1.25M 0.03%
19,332
+6,500
+51% +$440K
OMC icon
559
Omnicom Group
OMC
$21.6B
$1.24M 0.03%
17,901
-2,013
-10% -$152K
CLX icon
560
Clorox
CLX
$11.6B
$1.24M 0.03%
11,942
-337
-3% -$36.4K
ETV
561
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.71B
$1.24M 0.03%
83,700
SJT
562
San Juan Basin Royalty Trust
SJT
$117M
$1.24M 0.03%
115,287
-54,113
-32% -$600K
EEFT icon
563
Euronet Worldwide
EEFT
$2.72B
$1.23M 0.03%
20,008
TOL icon
564
Toll Brothers
TOL
$13.6B
$1.23M 0.03%
32,097
-1,544
-5% -$57.8K
FXL icon
565
First Trust Technology AlphaDEX Fund
FXL
$2.53B
$1.22M 0.03%
34,615
+26,569
+330% +$970K
WST icon
566
West Pharmaceutical
WST
$24B
$1.22M 0.03%
20,983
-617
-3% -$34.4K
NS
567
DELISTED
NuStar Energy L.P.
NS
$1.22M 0.03%
20,500
+15,100
+280% +$955K
HPQ icon
568
HP
HPQ
$24.9B
$1.21M 0.03%
88,443
-92,108
-51% -$1.37M
ROST icon
569
Ross Stores
ROST
$80.5B
$1.2M 0.03%
+24,780
New +$1.25M
FE icon
570
FirstEnergy
FE
$28B
$1.2M 0.03%
36,935
-444
-1% -$15.5K
DBI icon
571
Designer Brands
DBI
$307M
$1.19M 0.03%
35,683
+2,322
+7% +$82.9K
HQL
572
abrdn Life Sciences Investors
HQL
$581M
$1.18M 0.03%
41,949
-3,819
-8% -$106K
SLV icon
573
iShares Silver Trust
SLV
$28B
$1.18M 0.03%
78,674
-1,450
-2% -$22.8K
MAR icon
574
Marriott International
MAR
$98.3B
$1.18M 0.03%
15,816
+12,750
+416% +$1.01M
INGN icon
575
Inogen
INGN
$175M
$1.18M 0.03%
26,350
-4,000
-13% -$153K

Similar funds

Oppenheimer & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Oppenheimer & Co held 1,643 positions worth $3.59B, down 2.1% from $3.67B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q2 2015 filing shows 159 new, 579 increased, 611 reduced and 173 closed positions. Its largest new stake was Southwestern Energy Company: 251,114 shares worth $5.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

  • Oppenheimer & Co's largest Q2 2015 buy was Southwestern Energy Company: 251,114 shares worth $5.71M.
  • Oppenheimer & Co added most to Gilead Sciences in Q2 2015, an estimated $52.5M increase.
  • Oppenheimer & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $70.4M.
  • Oppenheimer & Co fully exited Vanguard Total Bond Market in Q2 2015, selling an estimated $12.6M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.59B portfolio in Q2 2015.
  • Oppenheimer & Co opened 159 new positions and closed 173 in Q2 2015.
  • Oppenheimer & Co's portfolio value fell 2.1% quarter-over-quarter to $3.59B.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.